
Opinion|Videos|January 23, 2025 (Updated: January 23, 2025)
Abiraterone Acetate Versions for Treatment of mCRPC
Author(s)Jose De La Cerda III, MD, MPH
This video segment explores how to choose between the original brand, generic, and micronized versions of abiraterone, considering factors like efficacy, cost, patient preference, and clinical context.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Abiraterone is now available as the original brand, generic and micronized versions. How do you choose between these different options of abiraterone?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5







